Abstract
Sixty-nine patients with malignant glioma received multimodality adjuvant therapy postoperatively. The patients were divided into three treatment groups. Group A (n=21) was treated with radiochemotherapy, Group B (n=21) with radiochemoimmunotherapy, and Group C (n=27) with radiotherapy alone. The effectiveness of each adjuvant mode of therapy was statistically compared in terms of the objective regression of the tumor and by survival curves. The results of this study indicate the importance of chemotherapy with ACNU and immunotherapy with N-CWS in the treatment of malignant gliomas.
